A recent study from Stanford University School of Medicine showed that the mortality rate from BC in the United States decreased by 58% absolutely in 2019 compared with 1975, especially a 71% decrease in ER + /HER2 + BC [19]. This evidence concerns the gene ERBB2 and breast cancer.